Sex differences in tolerability and response to immune checkpoint inhibitors in non-small cell lung cancer patients

被引：0
|
作者：
Duma, Narjust [1 ]
Azzouqa, Abdel-Ghani [1 ]
Yadav, Siddhartha [1 ]
Hoversten, Kahterine [1 ]
Reed, Clay [1 ]
Sitek, Andrea [1 ]
Enninga, Elizabeth [1 ]
Paludo, Jonas [1 ]
Kottschade, Lisa [1 ]
Mansfield, Aaron [1 ]
Manochakian, Rami [1 ]
Dronca, Roxana [1 ]
Adjei, Alex [1 ]
机构：
[1] Mayo Clin, Rochester, MN USA
来源：
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION | 2020年 / 29卷 / 06期
关键词：
D O I：
10.1158/1538-7755.DISP18-A120
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A120
引用
下载
收藏
页数：2
相关论文
共 50 条
  • [41] The Role of Intratumor Heterogeneity in the Response of Metastatic Non-Small Cell Lung Cancer to Immune Checkpoint Inhibitors
    Nicos, Marcin
    Krawczyk, Pawel
    Crosetto, Nicola
    Milanowski, Janusz
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [42] Immune checkpoint inhibitors for every patient with non-small cell lung cancer? Update on immunotherapy in patients with lung cancer
    Vansteenkiste, Johan F.
    ESMO OPEN, 2018, 3 (06)
  • [43] Efficacy and tolerance of immune checkpoint inhibitors for non-small cell lung cancer patients with interstitial lung disease
    Kobayashi, Haruki
    RESPIROLOGY, 2020, 25 (08) : 892 - 893
  • [44] Efficacy and tolerance of immune checkpoint inhibitors for non-small cell lung cancer patients with interstitial lung disease
    Matsumoto, Kinnosuke
    Adachi, Yuichi
    Enomoto, Takatoshi
    RESPIROLOGY, 2020,
  • [45] Analysis of immune checkpoint inhibitors for advanced non-small cell lung cancer in patients receiving antacids
    Isono, Taisuke
    Furuno, Hajime
    Onodera, Yoko
    Maruyama, Tomoya
    Takeuchi, Yuki
    Kojima, Ayaka
    Nishida, Takashi
    Kobayashi, Yoichi
    Ishiguro, Takashi
    Takaku, Yotaro
    Kurashima, Kazuyoshi
    Kagiyama, Naho
    RESPIRATORY INVESTIGATION, 2024, 62 (06) : 951 - 959
  • [46] Explore the efficacy of immune checkpoint inhibitors in non-small cell lung cancer patients of different gender
    Zheng, S-Y.
    Cui, H-J.
    ANNALS OF ONCOLOGY, 2020, 31 : S715 - S715
  • [47] Immune-checkpoint inhibitors in non-small cell lung cancer: A tool to improve patients' selection
    Banna, Giuseppe Luigi
    Passiglia, Francesco
    Colonese, Francesca
    Canova, Stefania
    Menis, Jessica
    Addeo, Alfredo
    Russo, Antonio
    Cortinovis, Diego Luigi
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2018, 129 : 27 - 39
  • [48] Prognostic effect of cachexia in patients with non-small cell lung cancer receiving immune checkpoint inhibitors
    Matsuo, Norikazu
    Azuma, Koichi
    Murotani, Kenta
    Murata, Daiki
    Matama, Goushi
    Kawahara, Akihiko
    Kojima, Takashi
    Tokito, Takaaki
    Hoshino, Tomoaki
    THORACIC CANCER, 2023, 14 (15) : 1362 - 1367
  • [49] Evaluating the effect of immune checkpoint inhibitors on venous thromboembolism in non-small cell lung cancer patients
    He, Xin
    Wei, Shan-Na
    Qin, Wen-Wen
    Geng, Nan
    Li, Bin
    Song, Shan
    Wang, Ping
    EXPERT REVIEW OF HEMATOLOGY, 2023, 16 (12) : 1135 - 1142
  • [50] Patterns of Failure in Patients With Advanced Non-Small Cell Lung Cancer Treated With Immune Checkpoint Inhibitors
    Chai, Rong
    Yin, Yipengchen
    Cai, Xuwei
    Fu, Xiaolong
    Zhang, Qin
    FRONTIERS IN ONCOLOGY, 2021, 11
12345